Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Neuro-Oncology|August 4, 2005
Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cellsSean D McAllister, Calvin Chan, Ryan J Taft, et al.
Methods and Protocols|May 23, 2023
Automated Dashboards for the Identification of Pathogenic Circulating Tumor DNA Mutations in Longitudinal Blood Draws of Cancer PatientsAleksandr Udalov, Lexman Kumar, Anna N Gaudette, et al.
Cannabis and Cannabinoid Research|April 29, 2021
Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various OriginsPierre-Yves Desprez, Ryuichi Murase, Chandani Limbad, et al.
Journal of Medicinal Chemistry|November 14, 2003
An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding regionSean D McAllister, Gulrukh Rizvi, Sharon Anavi-Goffer, et al.
Neuro-Oncology Advances|March 31, 2022
Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor modelsLiliana Soroceanu, Eric Singer, Pratiksha Dighe, et al.
Biochemical Pharmacology|July 12, 2002
A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognitionSean D McAllister, Qing Tao, Judy Barnett-Norris, et al.
British Journal of Pharmacology|June 10, 2014
Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancerRyuichi Murase, Rumi Kawamura, Eric Singer, et al.
Molecular Cancer Therapeutics|January 8, 2010
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survivalJahan P Marcu, Rigel T Christian, Darryl Lau, et al.
Breast Cancer Research and Treatment|September 23, 2010
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasisSean D McAllister, Ryuichi Murase, Rigel T Christian, et al.
Cancer Research|December 18, 2012
Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic targetLiliana Soroceanu, Ryuichi Murase, Chandani Limbad, et al.
Pageof 3